Prospective evaluation of CT-guided HDR brachytherapy as a  local ablative treatment for renal masses: a single-arm pilot trial.

CONCLUSION: HDR-BT is a feasible and safe technique for the local ablation of renal masses. A phase II study is recruiting to evaluate the efficacy of this novel local ablative treatment in a larger study population.
PMID: 31346674 [PubMed - as supplied by publisher]

Source: Nuklearmedizin - July 24, 2019 Category: Radiology Authors: Damm R, Streitparth T, Hass P, Seidensticker M, Heinze C, Powerski M, Wendler JJ, Liehr UB, Mohnike K, Pech M, Ricke J Tags: Strahlenther Onkol Source Type: research